Wells Fargo & Company Athenex, Inc. Transaction History

Wells Fargo & Company

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 13, 2023	SELL	$0.12 - $0.21 $5,098 - $8,922	-42,490 Reduced 83.78%	8,225 $1,000
Q3 2022 Nov 14, 2022	BUY	$0.24 - $1.11 $6,033 - $27,906	25,141 Added 98.31%	50,715 $14,000
Q2 2022 Aug 12, 2022	SELL	$0.41 - $0.91 $20,563 - $45,641	-50,155 Reduced 66.23%	25,574 $10,000
Q1 2022 May 16, 2022	SELL	$0.79 - $1.59 $58,881 - $118,509	-74,534 Reduced 49.6%	75,729 $62,000
Q4 2021 Feb 14, 2022	SELL	$1.36 - $2.94 $89,464 - $193,402	-65,783 Reduced 30.45%	150,263 $204,000
Q3 2021 Nov 15, 2021	BUY	$2.97 - $4.84 $147,139 - $239,783	49,542 Added 29.75%	216,046 $650,000
Q2 2021 Aug 16, 2021	SELL	$3.71 - $5.13 $313,947 - $434,110	-84,622 Reduced 33.7%	166,504 $769,000
Q1 2021 May 13, 2021	SELL	$4.08 - $14.75 $112,852 - $407,985	-27,660 Reduced 9.92%	251,126 $1.08 Million
Q4 2020 Feb 09, 2021	BUY	$11.06 - $14.01 $658,291 - $833,875	59,520 Added 27.15%	278,786 $3.08 Million
Q3 2020 Nov 05, 2020	SELL	$10.26 - $14.55 $72,753 - $103,174	-7,091 Reduced 3.13%	219,266 $2.65 Million
Q2 2020 Aug 13, 2020	BUY	$7.11 - $13.76 $86,379 - $167,170	12,149 Added 5.67%	226,357 $3.12 Million
Q1 2020 May 14, 2020	BUY	$5.71 - $15.85 $1.22 Million - $3.4 Million	214,208 New	214,208 $1.66 Million

1.46M

Ticker ATNX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 156,790,000
Market Cap $1.57M
Description
Athenex, Inc., a biopharmaceutical company, engages in the discovery, development, and commercialization of drugs for the treatment of cancer. It operates through three segments: Oncology Innovation Platform, Global Supply Chain Platform, and Commercial Platform. The company's Orascovery product candidates include Oral paclitaxel and encequidar,...

Get notified when there are updates to the investment portfolio of Wells Fargo & Company, based on Form 13F filings with the SEC.

Stay updated on Wells Fargo & Company with notifications on news.